Einträge von Ziemer, Mirjana auf dem Publikationsserver

Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian , Gutzmer, Ralf, Meier, Friedegund , Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian , Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Simon, Jan-Christoph, Herbst, Rudolf A., Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M., Terheyden, Patrick, Stadler, Rudolf, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C. und Schadendorf, Dirk (2022) Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. The Lancet 400 (10358), S. 1117-1129. Volltext nicht vorhanden.

Zhang, Yun, Shen, Lichong, Dreißigacker, Katja, Zhu, Honglin, Trinh-Minh, Thuong, Meng, Xianyi, Tran-Manh, Cuong, Dees, Clara, Matei, Alexandru-Emil, Chen, Chih-Wei, Ditschkowski, Markus, Krauss, Stefan, Winkler, Julia, Wolff, Daniel, Ziemer, Mirjana, Beilhack, Andreas, Karrer, Sigrid, Herr, Wolfgang, Mackensen, Andreas, Schett, Georg, Spriewald, Bernd M. und Distler, Jörg H. W. (2021) Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood 137 (17), S. 2403-2416. Volltext nicht vorhanden.

Steeb, Theresa, Wessely, Anja, Alter, Mareike, Bayerl, Christiane, Bender, Armin, Bruning, Guido, Dabrowski, Evelyn, Debus, Dirk, Devereux, Nina, Dippel, Edgar, Drexler, Konstantin, Dücker, Pia, Dummer, Reinhard, Emmert, Steffen, Elsner, Peter, Enk, Alexander, Gebhardt, Christoffer, Gesierich, Anja, Goebeler, Matthias, Goerdt, Sergij, Goetze, Steven, Gutzmer, Ralf, Haferkamp, Sebastian, Hansel, Gesina, Hassel, Jessica C., Heinzerling, Lucie, Kähler, Katharina C., Kaume, Kjell M., Krapf, Wolfgang, Kreuzberg, Nicole, Lehmann, Percy, Livingstone, Elisabeth, Löffler, Harald, Loquai, Carmen, Mauch, Cornelia, Mangana, Johanna, Meier, Friedegund, Meissner, Markus, Moritz, Rose K. C., Maul, Lara Valeska, Müller, Verena, Mohr, Peter, Navarini, Alexander, Van Nguyen, Ahn, Pfeiffer, Christiane, Pföhler, Claudia, Posch, Christian, Richtig, Erika, Rompel, Rainer, Sachse, Michael M., Sauder, Stefanie, Schadendorf, Dirk, Schatton, Kerstin, Schulze, Hans-Joachim, Schultz, Erwin, Schilling, Bastian, Schmuth, Matthias, Simon, Jan. C., Streit, Markus, Terheyden, Patrick, Thiem, Alexander, Tüting, Thomas, Welzel, Julia, Weyandt, Gerhard, Wesselmann, Ulrich, Wollina, Uwe, Ziemer, Mirjana, Zimmer, Lisa, Zutt, Markus, Berking, Carola, Schlaak, Max und Heppt, Markus V. (2020) Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG). Journal of Cancer Research and Clinical Oncology 147 (6), S. 1763-1771.

Heppt, Markus V., Heinzerling, Lucie, Kähler, Katharina C., Forschner, Andrea, Kirchberger, Michael C., Loquai, Carmen, Meissner, Markus, Meier, Friedegund, Terheyden, Patrick, Schell, Beatrice, Herbst, Rudolf, Göppner, Daniela, Kiecker, Felix, Rafei-Shamsabadi, David, Haferkamp, Sebastian, Huber, Margit A., Utikal, Jochen, Ziemer, Mirjana, Bumeder, Irmgard, Pfeiffer, Christiane, Schäd, Susanne G., Schmid-Tannwald, Christoph, Tietze, Julia K., Eigentler, Thomas K. und Berking, Carola (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. European Journal of Cancer 82, S. 56-65. Volltext nicht vorhanden.